LAG3 PET Imaging in Advanced Solid Tumors

NCT04706715 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Solid Tumor

Interventions

OTHER: 89Zr-DFO-REGN3767
DRUG: Cemiplimab

Sponsor

University Medical Center Groningen

Collaborators

[object Object]